Oversight of DOAC Prescribing Beneficial for A-Fib, VTE Patients
Oversight identifies errors, especially in a-fib patients, who mainly have alerts for off-label prescribing during follow-up period
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.